153 related articles for article (PubMed ID: 33002918)
1. Nonkeratinizing Squamous Cell Carcinoma of the Sinonasal Tract With DEK-AFF2: Further Solidifying an Emerging Entity.
Bishop JA; Gagan J; Paterson C; McLellan D; Sandison A
Am J Surg Pathol; 2021 May; 45(5):718-720. PubMed ID: 33002918
[No Abstract] [Full Text] [Related]
2. Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity.
Todorovic E; Truong T; Eskander A; Lin V; Swanson D; Dickson BC; Weinreb I
Am J Surg Pathol; 2020 Sep; 44(9):1244-1250. PubMed ID: 32366754
[TBL] [Abstract][Full Text] [Related]
3. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
[TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract.
Kuo YJ; Lewis JS; Truong T; Yeh YC; Chernock RD; Zhai C; Chen YA; Hongo T; Lee CK; Shi Q; Velez Torres JM; Geromes AB; Chu YH; Hsieh MS; Yamamoto H; Weinreb I; Hang JF
Mod Pathol; 2022 Nov; 35(11):1587-1595. PubMed ID: 35701667
[TBL] [Abstract][Full Text] [Related]
5. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.
Kuo YJ; Lewis JS; Zhai C; Chen YA; Chernock RD; Hsieh MS; Lan MY; Lee CK; Weinreb I; Hang JF
Mod Pathol; 2021 Oct; 34(10):1820-1830. PubMed ID: 34108636
[TBL] [Abstract][Full Text] [Related]
6. DEK::AFF2 Fusion Carcinomas of Head and Neck.
Ruangritchankul K; Sandison A
Adv Anat Pathol; 2023 Mar; 30(2):86-94. PubMed ID: 36221219
[TBL] [Abstract][Full Text] [Related]
7. [Primary DEK::AFF2 fusion positive nonkeratinizing squamous cell carcinoma of the middle ear: report of a case].
Yu ST; Ye XZ; Xu BQ; Ouyang XJ; Zhang JQ; Qu LJ
Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1058-1060. PubMed ID: 37805405
[TBL] [Abstract][Full Text] [Related]
8. First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.
Savari O; Chang JC; Bishop JA; Sakthivel MK; Askin FB; Rekhtman N
J Thorac Oncol; 2022 Aug; 17(8):1050-1053. PubMed ID: 35773081
[TBL] [Abstract][Full Text] [Related]
9. Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature.
Yuzawa S; Michizuka T; Kakisaka R; Ono Y; Hayashi M; Takahara M; Katada A; Mizukami Y; Tanino M
Diagn Pathol; 2023 Apr; 18(1):44. PubMed ID: 37041626
[TBL] [Abstract][Full Text] [Related]
10. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
11. [Sinonasal neoplasms: Update from the WHO 2022].
Agaimy A
Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
[TBL] [Abstract][Full Text] [Related]
12. Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.
Miller DL; Palsgrove DN; Rijal A; Hathuc V; Chernock R; Gagan J; Bishop JA
Head Neck Pathol; 2022 Sep; 16(3):928-933. PubMed ID: 35218513
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas.
Ng JKM; Chow C; Tang CY; Chan AZ; Li JJX; Chan ABW
Virchows Arch; 2024 Jan; 484(1):119-125. PubMed ID: 38063896
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic algorithm for sinonasal papillary non-keratinizing squamous cell carcinoma with DEK::AFF2 fusion and mimickers.
Laforga JB; Othman BK
Rev Esp Patol; 2024; 57(1):67-70. PubMed ID: 38246714
[TBL] [Abstract][Full Text] [Related]
15.
Laforga JB; Abdullah B
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3866-3870. PubMed ID: 37974682
[TBL] [Abstract][Full Text] [Related]
16. Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.
Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
[TBL] [Abstract][Full Text] [Related]
17. Translocations and Gene Fusions in Sinonasal Malignancies.
Larkin R; Hermsen MA; London NR
Curr Oncol Rep; 2023 Apr; 25(4):269-278. PubMed ID: 36753024
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between DEK oncogene expression and oral squamous cell carcinoma].
Wang X; Huang SH; Yu LQ; Liu J; Diao Y; Sun CF
Shanghai Kou Qiang Yi Xue; 2014 Feb; 23(1):75-9. PubMed ID: 24608617
[TBL] [Abstract][Full Text] [Related]
19. The First Report of Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma on Fine-Needle Aspiration.
Li JJX; Ng JKM; Chan ABW
Head Neck Pathol; 2023 Dec; 17(4):1058-1063. PubMed ID: 37938508
[TBL] [Abstract][Full Text] [Related]
20. All hands on DEK.
Bodine DM
J Clin Invest; 2019 May; 129(6):2205-2206. PubMed ID: 31107244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
